期刊文献+

重症肌无力患者外周血CD_4^+CD_(25)^(high)T细胞及其动态观察 被引量:6

Dynamic study of circulating CD_4^+CD_(25)^(high) T cells in myasthenia gravis
原文传递
导出
摘要 目的研究重症肌无力(myastheniagravis,MG)患者外周血CD4+CDh25ighT细胞的水平,以及各种治疗方法对其的影响。方法应用四色流式细胞仪检测55例MG患者(治疗前)与33名健康对照外周血CD4+CDh25ighT细胞百分率,对其中26例MG患者进行了治疗前后的动态检测。结果MG患者与健康对照外周血CD4+CD2h5ighT细胞百分率分别为6·22%±3·37%与5·16%±1·87%,两者差异无统计学意义(P=0·061),而21例非手术治疗患者其外周血CD4+CD2h5ighT细胞百分率的变化与病情评分的变化呈负相关(r=-0·563,P=0·008)。结论这种非手术治疗前后短期内的CD4+CD2h5ighT细胞的变化情况可能与病情相关,但胸腺切除前阶段观察的情况有所不同。 Objective To observe the difference of blood CD4^+CD25^high T cells between the myasthenia gravisc (MG) patients and healthy controls and to investigate the dynamic changes of the cells in MG patients with various treatments. Methods The peripheral blood CD4^+CD25^high T cells of 55 MG patients (before any treatment ) and 33 healthy controls were detected by four-color flow cytometry. And 26 MG patients were detected before and after various treatments. Results There was no significant difference of the percentage of CD4^+CD25^high T cells between MG patients (6. 22% ± 3.37% ) and the healthy control (5.16% ± 1.87%, P = 0. 061 ). The increase of the percentage of CD4^+CD25^high T cells had a negative correlation with the decrease of MGFA of 21 patients after short-term non-operated treatment (r = - 0. 563, P = 0. 008 ). Conclusions Our observations have indicated that short-term changes of the percentage of CD4^+CD25^high T cells in MG patients might be related to the disease. Except thymectomy, other treatments contribute to the increase of peripheral CD4^+CD25^high T cells in MG patients in a short term.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2006年第11期766-770,共5页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(30571727)
关键词 重症肌无力 T淋巴细胞亚群 免疫疗法 Myasthenia gravis T-lymphocyte subsets Immunotherapy
  • 相关文献

参考文献19

  • 1Berrih-Aknin S.Myasthenia gravis,a model of organ-specific autoimmune disease.J Autoimmun,1995,8:139-143.
  • 2Link H,Olsson O,Sun J,et al.Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.J Clin Invest,1991,87:2191-2196.
  • 3Ahlberg R,Yi Q,Pirskanen R.Treatment of myasthenia gravis with anti-CD4 antibody:improvement correlates to decreased T-cell autoreactivity.Neurology,1994,44:1732-1737.
  • 4Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol,1995,155:1151-1164.
  • 5Baecher-Allan C,Brown JA,Freeman GJ,et al.CD+4CDhigh25 regulatory cells in human peripheral blood.J Immunol,2001,167:1245-1253.
  • 6Ng WF,Duggan PJ,Ponchel F,et al.Human CD4+CD25+cells:a naturally occurring population of regulatory T cells.Blood,2001,98:2736-2744.
  • 7Jaretzki A 3rd,Barohn RJ,Ernstoff RM,et al.Myasthenia gravis:recommendations for clinical research standards.Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.Neurology,2000,55:16-23.
  • 8Xiao BG,Lu CZ,Hojeberg B,et al.Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis.J Neurol Sci,1991,105:118-123.
  • 9Mestre M,Gonzalez C,Grino JM,et al.Sequential monitoring of immunoregulatory T cell subsets in renal transplantation.Transplant Proc,1992,24:73-75.
  • 10Robert W,Arthur M,Hans L.Altered tumor growth factor β mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis.Neurol Sci,1997,151:49-55.

同被引文献119

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部